Short Title: Medrad MRXperion MR Injection System

Document Type: Pre-solicitation Notice
Solicitation Number: N02CO84103-33
Posted Date: 08/31/2018
Response Date: 09/07/2018 3:00 PM ET
Classification Code: 6640
NAICS Code: 339112 Surgical and Medical Instrument Manufacturing

Contracting Office Address
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E148, Rockville, MD 20850, UNITED STATES

Description

The purpose of this requirement is to procure and install a Medrad MRXperion MR Injection System for the National Cancer Institute (NCI), Center for Cancer Research (CCR), Molecular Imaging Program (MIP). The requirement includes the instrument, installation, and user training.

This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1 (b)(2) and 13.501-(a)(1) using simplified acquisition procedures for commercial acquisitions. The North American Industry Classification System code is 339112 and the business size standard is 1,000 employees.

Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. The period of performance shall be 12 months from the date of award.

It has been determined there are no opportunities to acquire green products or services for this procurement.

Objective

The mission of the Molecular Imaging Program is to advance cancer therapies using molecular imaging. The Molecular Imaging Program (MIP) conducts research in designing, developing and testing new novel targeted imaging agents for the detection and characterization of cancer. These imaging agents include tissue-specific MRI, Positron Emission Tomography (PET), radionuclide, and optical probes. The primary focus is on the clinical translation of targeted imaging agents for cancer imaging.

The Contractor shall provide a Medrad MRXperion MR Injection System

PRODUCT FEATURES/SALIENT CHARACTERISTICS

The following product features/characteristics are required for this requirement. The system shall:

• Be compatible with Medrad injection syringes (XP 65/115 VS)
• Be compatible with an MRI scanner
• Have automatic priming and filling
• Be capable of being interfaced with Clinical Center's CRIS (Clinical Records Information System)
• Have automatic plunger advance and retraction and attaching and detaching the syringes
• Have a small footprint - maximum dimensions: 23.3" (W) x 23.3" (D)
• Have on board eGFR (estimate glomerulus filtration rate) and weight based dosing calculators
• Have a minimum one year warranty on the system
• Include installation and training

DELIVERY / INSTALLATION

Delivery Address: NCI Molecular Imaging Program, 9000 Rockville Pike, Bldg 10, Room B3B69, Bethesda, MD 20892

TRAINING

Training will be given onsite after the instrument has been installed and the appropriate personnel are available for training.

This notice is a request for competitive quotations. However, if any interested party, especially small business believes it can meet the above requirement, it may submit a proposal or quote for the Government to consider. The response and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. All questions must be received by September 5, 2018. All responses must be sent to contracting office by 12:00 PM ET, on Friday, September 7, 2018, via email to William Neal, Contracting Officer at [email protected]. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must be registered and have valid certification through SAM.GOV and have Representations and Certifications filled out. Reference: N02CO84103-33 on all correspondence.